Literature DB >> 9787974

Adverse skin reactions to the nicotine transdermal system.

R Wolf1, B Tüzün, Y Tüzün.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9787974     DOI： 10.1016/s0738-081x(98)00047-9

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  2 in total

1.  Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease.

Authors:  Jeffrey L Cummings; Martin R Farlow; Xiangyi Meng; Sibel Tekin; Jason T Olin
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 2.  Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch.

Authors:  C Sadowsky; J A Davila Perez; R W Bouchard; I Goodman; S Tekin
Journal:  CNS Neurosci Ther       Date:  2010       Impact factor: 5.243
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.